Paolo Piacentini

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Nanomedicine, Oncology, Pancreatic Cancer +8

ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population

Elisa Benetti, Rossella Tita, Ottavia Spiga et al. · European Journal of Human Genetics · 2020 · 267 citations · Full text

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

Chiara Fallerini, Sergio Daga, Stefania Mantovani et al. · eLife · 2021 · 207 citations · Full text

Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine

Massimo Donadelli, Chiara Costanzo, Stefania Beghelli et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 2007 · 156 citations

Tumor Biology, Pancreatic Cancer, Medicine +8

Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation

Paolo Piacentini, Massimo Donadelli, Chiara Costanzo et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2006 · 76 citations

Chemotherapeutic Agents, Tumor Biology, Oncology +7